Heart fatty-acid binding protein (h-FABP): A new cardiac marker;Un nouveau marqueur cardiaque: La heart fatty-acid binding protein (h-FABP)

Annales de Biologie Clinique

Volumn 64, Issue 3, 2006, Pages 209-217

  Servonnet, A ^a   Delacour, H ^a   Dehan, C ^a   Gardet, V ^a  

^a HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

Author keywords

Acute coronary syndrome; Cardiac marker; Coronary reperfusion; h FABP

Indexed keywords

BIOLOGICAL MARKER; FABP3 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

BLOOD; HEART DISEASE; HUMAN; REVIEW;

BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; HEART DISEASES; HUMANS;

EID: 33744955396     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Debierre V, Longo C, Potel G. Prise en charge du syndrome coronarien aigu à domicile. Urgence pratique 2005 ; 70 : 37-9.
2. Dujardin JJ, Cambou JP. Épidémiologie de l'infarctus du myocarde. EMC Cardiologie-Angiologie ; 2006 : sous presse.
3. Organisation Mondiale de la Santé. Statistiques sur les causes de mortalité. Site internet www.who.int consulté le 25 septembre 2005.
4. Bertrand ME, Simoons ML, Fox KA, et al. Task Force on the Management of acute coronary syndromes of the European society of cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002 ; 23 : 1809-40.
5. Braunwald E, Antman EM, Beasley JW, et al. American college of cardiology. American heart association. Committee on the management of patients with unstable angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 2002 ; 40 : 1366-74.
6. The joint European society of cardiology/American college of cardiology committee. Myocardial infarction redefined - a consensus document of the joint European society of cardiology/American college of cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000 ; 21 : 1502-13.
7. Ockner RK, Manning JA, Poppenhausen RB, Ho WKL. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science 1972 ; 177 : 56-8.
8. Alhadi HA, Fox KAA. Do we need additional markers of myocyte necrosis : the potential value of heart fatty-acid-binding protein. Q J Med 2004 ; 97 : 187-98.
9. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins : their function and physiological significance. Prog Lipid Res 1996 ; 35 : 243-82.
10. Pelsers MM, Hanhoff T, Van der Voort D, et al. Brain- and heart-type fatty acid-binding proteins in the brain : tissue distribution and clinical utility. Clin Chem 2004 ; 50 : 1568-75.
11. Pelsers MM, Hermens WT, Glatz JFC. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chem Acta 2005 ; 352 : 15-35.
12. Memon RA, Bass NM, Moser AH, et al. Down regulation of liver and heart fatty acid binding proteins by endotoxin and cytokines in vivo. Biochim Biophys Acta 1999 ; 1440 : 118-26.
13. Glatz JF, Van Bilsen M, Paulussen RJ, Veerkamp JH, Van der Vusse GJ, Reneman RS. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988 ; 961 : 148-52.
14. Fournier N, Geoffroy M, Deshusses J. Purification and characterization of a long-chain fatty acid binding protein supplying the mitochondrial β-oxydative system in the heart. Biochim Biophys Acta 1978 ; 533 : 457-64.
15. Troxler RF, Offner GD, Jiang JW, et al. Localization of the gene for human heart fatty-acid-binding protein to chromosome 1p32-1p33. Hum Genet 1993 ; 92 : 563-6.
16. Watanabe K, Wakabayashi H, Veerkamp JH, Ono T, Suzuki T. Immunohistochemical distribution of heart-type fatty acid binding protein immunoreactivity in normal human tissues and in acute myocardial infarct. J Pathol 1993 ; 170 : 59-65.
17. Glatz JF, Paulussen RJ, Veerkamp JH. Fatty acid binding proteins from heart. Chem Phys Lipids 1985 ; 38 : 115-29.
18. Unterberg C, Heidl G, Von Bassewitz DB, Spener F. Isolation and characterization of the fatty acid-binding protein from human heart. J Lipid Res 1986 ; 27 : 1287-93.
19. Offner GD, Brecher P, Sawlivich WB, Costello CE, Troxler RF. Characterization and amino acid sequence of a fatty acid-binding protein from human heart. Biochem J 1988 ; 252 : 191-8.
20. Schroeder F, Jolly CA, Cho TH, Frolov A. Fatty acid binding protein isoforms : structure and function. Chem Phys Lipids 1988 ; 92 : 1-25.
21. Pelsers MM, Chapelle JP, Knapen M, et al. Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 1999 ; 45 : 441-3.
22. Wodzig KW, Pelsers MM, van der Vusse GJ, Roos W, Glatz JF. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem 1997 ; 34 : 263-8.
23. Schreiber A, Feldbrugge R, Key G, Glatz JF, Spener F. An immunosensor based on disposable electrodes for rapid estimation of fatty acid-binding protein, an early marker of myocardial infarction. Biosens Bioelectron 1997 ; 12 : 1131-7.
24. Robers M, Van der Hulst FF, Fischer M, et al. Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction. Clin Chem 1998 ; 44 : 1564-7.
25. Watanabe T, Ohkubo Y, Matsuoka H, et al. Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein. Clin Biochem 2001 ; 34 : 257-63.
26. O'Regan TM, Pravda M, O'Sullivan CK, Guilbault GG. Development of a disposable immunosensor for the detection of human heart fatty acid-binding protein in whole blood using screen-printed carbon electrodes. Talanta 2002 ; 57 : 501-10.
27. Van der Voort D, Pelsers MM, Korf J, Hermens WT, Glatz JF. Development of a displacement immunoassay for human heart-type fatty acid-binding protein in plasma : the basic conditions. Biosens Bioelectron 2003 ; 19 : 465-71.
28. Chan CP, Sum KW, Cheung KY, et al. Development of a quantitative lateral flow assay for rapid detection of fatty acid-binding protein. J Immunol Methods 2003 ; 279 : 91-100.
29. Keine AH, Glatz JF, van Nieuwenhoven FA, van der Vusse GJ. Release of heart fatty acid -binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992 ; 166 : 155-62.
30. Glatz JF, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998 ; 272 : 87-92.
31. Okamoto F, Sohmiya K, Ohkaru Y, et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000 ; 38 : 231-8.
32. Haastrup B, Gill S, Kristensen SR, et al. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 2000 ; 94 : 254-61.
33. Ghani F, Wu AH, Graff L, et al. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 2000 ; 46 : 718-9.
34. Ikeda J, Zenimoto M, Kita M, Mori M. Usefulness of cardiac troponin I in patients with acute myocardial infarction. Rinsho Byori 2002 ; 50 : 982-6.
35. Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 2003 ; 99 : 96-104.
36. Trifonov K, Katrukha AG, Iavelov IS, Averkov OV, Gratsianskii NA. Diagnostic value of heart fatty-acid binding protein in early hospitalized patients with non ST elevation acute coronary syndrome. Kardiologiia 2003 ; 43 : 4-8.
37. Chen L, Guo X, Yang F. Role of heart-type fatty acid binding protein in early detection of acute myocardial infarction in comparison with cTnI, CK-MB and myoglobin. J Huazhong Univ Sci Technolog Med Sci 2004 ; 24 : 449-51.
38. Seino Y, Ogata KI, Takano T, et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain : comparison with rapid troponin t and myoglobin tests. Am J Med 2003 ; 115 : 185-90.
39. Ecollan P, Boon G, Fievet ML, Haas R, Bertho N, Siami S, et al. Nouveau test diagnostic biologique en pré-hospitalier des patients présentant un syndrome coronarien aigu (ST+) dans les premières heures. Étude de faisabilité d'un test semi quantitatif de h-FABP : «Cardiodetect». Journées européennes de la Société française de cardiologie (JESCF), 22 janvier 2005.
40. Medkour F, Pellerin D, Fournier C, Assayag P. Traitements à la phase aiguë du l'infarctus du myocarde. Réanimation 2001 ; 10 : 196-204.
41. Ishii J, Nagamura Y, Nomura M, et al. Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid binding protein. Clin Chim Acta 1997 ; 262 : 13-27.
42. De Lemos JA, Antman E, Morrow DA, et al. Heart-Type Fatty Acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 2000 ; 298 : 85-97.
43. De Groot MJ, Muijtjens AM, Simoons ML, Hermens WT, Glatz JF. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma. Heart 2001 ; 85 : 278-85.
44. Van Nieuwenhoven FA, Kleine AH, Wodzig WH, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995 ; 92 : 2848-54.
45. Ishii J, Ozaki Y, Lu J, et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 2005 ; 51 : 1397-404.
46. Suzuki M, Hori S, Noma S, Kobayashi K. Prognostic value of a qualitative test for heart-type Fatty Acid-binding protein in patients with acute coronary syndrome. Int Heart J 2005 ; 46 : 601-6.
47. Erlikh AD, Katrukha AG, Trifonov IR, Bereznikova AV, Gratsianski NA. Prognostic significance of heart fatty acid binding protein in patients with non-st elevation acute coronary syndrome : results of follow-up for twelve months. Kardiologiia 2005 ; 45 : 13-21.
48. Glatz JF, Kleine AH, van Nieuwenhoven FA, Hermens WT, van Dieijen-Visser MP, van der Vusse GJ. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994 ; 71 : 135-40.
49. Wodzig KW, Kragten JA, Hermens WT, Glatz JF, van Dieijen-Visser MP. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem Clin Biochem 1997 ; 35 : 191-8.
50. De Groot MJ, Wodzig KW, Simoons ML, Glatz JF, Hermens WT. Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates. Cardiovasc Res 1999 ; 44 : 315-24.
51. Suzuki K, Sawa Y, Kadoba K, et al. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations. Ann Thorac Surg 1998 ; 65 : 54-8.
52. Petzold T, Feindt P, Sunderdiek U, Boeken U, Fisher Y, Gams E. Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg 2001 ; 19 : 859-64.
53. Hasegawa T, Yoshimura N, Oka S, Ootaki Y, Toyoda Y, Yamaguchi M. Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2004 ; 127 : 1697-702.
54. Liu H, Dong GH, Xu B, Shen Y, Jing H. Heart fatty acid binding protein in the rapid evaluation of myocardial damage following valve replacement surgery. Clin Chim Acta 2005 ; 356 : 147-53.
55. Sorichter S, Mair J, Koller A, Pelsers MM, Puschendorf B, Glatz JF. Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein. Br J Sports Med 1998 ; 32 : 121-4.
56. Van Nieuwenhoven FA, Kleine AH, Wodzig WH, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995 ; 92 : 2848-54.
57. Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JF. Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem 1997 ; 43 : 193-5.
58. Nayashida N, Chihara S, Tayama E, et al. Influence of renal function on serum and urinary heart fatty acid-binding protein levels. J Cardiovasc Surg (Torino) 2001 ; 42 : 735-40.